April 11, 2025 07:00 AM EDT
Peer Review

Ira Mell­man joins PI­CI; Vi­iV Health­care CMO re­places Chris Cor­si­co at GSK

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Lei Lei Wu

News Reporter

Af­ter 17 years at Genen­tech, Ira Mell­man is join­ing the Park­er In­sti­tute for Can­cer Im­munother­a­py as pres­i­dent of re­search. The PI­CI …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Makary wants to re­place an­i­mal test­ing with organoids. It may take a while

Mar­ket tur­moil is tank­ing biotech M&A and IPOs. Here's the play­book star­tups will use to sur­vive

Re­cruiters say some bio­phar­mas pause hir­ing as they strug­gle to make sense of on­go­ing un­cer­tain­ty

Phar­ma tar­iffs: Here’s what a po­ten­tial roll­out could look like

Bris­tol My­er­s' im­munother­a­py com­bo nets ap­provals in col­orec­tal and liv­er can­cer

Tome Bio founders wran­gle ‘jump­ing genes’ to cre­ate new pro­gram­ma­ble gene in­ser­tion tool

A service from the Financial Times